The antiproliferative effect of beta-carotene requires p21(waf1/cip1) in normal human fibroblasts

Citation
La. Stivala et al., The antiproliferative effect of beta-carotene requires p21(waf1/cip1) in normal human fibroblasts, EUR J BIOCH, 267(8), 2000, pp. 2290-2296
Citations number
43
Categorie Soggetti
Biochemistry & Biophysics
Journal title
EUROPEAN JOURNAL OF BIOCHEMISTRY
ISSN journal
00142956 → ACNP
Volume
267
Issue
8
Year of publication
2000
Pages
2290 - 2296
Database
ISI
SICI code
0014-2956(200004)267:8<2290:TAEOBR>2.0.ZU;2-2
Abstract
In normal human fibroblasts, beta-carotene induces a cell-cycle delay in th e G1 phase independent of its provitamin A activity via a mechanism not yet elucidated. In this study we provide biochemical evidence showing that del ayed progression through the G1 phase occurs concomitantly with: an increas e in both nuclear-bound and total p21(waf1/cip1) protein levels; an increas e in the amount of p21(waf1/cip1) associated with cdk4; the inhibition of c yclin D1-associated cdk4 kinase activity; and a reduction in the levels of hyperphosphorylated forms of retinoblastoma protein, and particularly, in p hosphorylated Ser780. The role of p21(waf1/cip1) in the antiproliferative e ffect of the carotenoid was further supported by genetic evidence that neit her changes in cell-cycle progression nor in the phosphorylation status of retinoblastoma protein were observed in p21(waf1/cip1)-deficient human fibr oblasts treated with beta-carotene. These results clearly demonstrate that p21(waf1/cip1) is involved directly in the molecular pathway by which beta- carotene inhibits cell-cycle progression.